Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Health care industry struggles to keep pace with ‘tectonic shift’ in paid family leave Rob Volansky
-
- ‘Bad for patients’: Rheumatologists express dismay over Roe v. Wade reversal Erich Martin
- FDA announces new Evusheld dosing guidelines, shelf-life extension Erich Martin
- FDA approves pegloticase, methotrexate combo in patients with uncontrolled gout
- FDA clears blood tests for systemic sclerosis, lupus diagnoses
- Q&A: Pegloticase sustained lower serum urate in kidney transplant recipients with gout Julie S. Keenan; Abdul Abdellatif, MD, FASN
- Q&A: ‘Primary prevention’ the biggest challenge in managing antiphospholipid syndrome Erich Martin
- Paid family leave ‘one important step’ to addressing equity in health care Grace C. Wright, MD, PhD
- Hooked on Rheum with Mark Genovese, MD Mark C. Genovese, MD
-
- Disease flares requiring therapy change ‘relatively uncommon’ after COVID-19 vaccination Erich Martin
- EULAR: Telehealth useful for disease monitoring; barriers to access exist Erich Martin
- Kawasaki disease incidence curbed by COVID-19 lockdown behaviors Erich Martin
- Meaningful clinical data on cannabis use in rheumatic diseases still lacking Erich Martin
- Patients with IMIDs respond well to third COVID-19 vaccine dose Erich Martin
- Patients with osteoarthritis who walk for exercise less likely to develop new knee pain Erich Martin
- Patients with SSc-related digital ulcers use ‘significantly more’ health care resources Erich Martin
- Risk for adverse pregnancy outcomes greater in systemic sclerosis than lupus Erich Martin
-
- Uncertainty leads to depression, anxiety in patients with systemic autoimmune diseases Erich Martin
- Urate-lowering therapy use, target achievement remain low in United Kingdom Erich Martin
- Younger patients on public insurance at highest risk for lupus hospital readmission Erich Martin
- EULAR: Taper, discontinue glucocorticoids in rheumatoid arthritis as soon as feasible Erich Martin
- ‘You’re not alone’: What rheumatologists need to know about ILD, PAH in scleroderma Erich Martin